No abstract available
MeSH terms
-
Aged
-
Angioplasty / adverse effects
-
Angioplasty / methods
-
Aryl Hydrocarbon Hydroxylases / antagonists & inhibitors
-
Aryl Hydrocarbon Hydroxylases / genetics
-
Aryl Hydrocarbon Hydroxylases / metabolism
-
Aspirin / antagonists & inhibitors*
-
Aspirin / pharmacology
-
Cell Adhesion Molecules / metabolism*
-
Clopidogrel
-
Coronary Disease / complications
-
Coronary Disease / genetics
-
Coronary Disease / metabolism*
-
Coronary Disease / surgery
-
Cytochrome P-450 CYP2C19
-
Drug Antagonism
-
Enzyme Inhibitors / pharmacology
-
Female
-
Humans
-
Male
-
Microfilament Proteins / metabolism*
-
Mixed Function Oxygenases / antagonists & inhibitors
-
Mixed Function Oxygenases / genetics
-
Mixed Function Oxygenases / metabolism
-
Omeprazole / antagonists & inhibitors*
-
Omeprazole / pharmacology
-
Phosphoproteins / metabolism*
-
Phosphorylation / drug effects
-
Platelet Activation / drug effects*
-
Platelet Activation / genetics
-
Platelet Aggregation Inhibitors / pharmacology
-
Platelet Function Tests / methods
-
Polymorphism, Single Nucleotide
-
Protein Processing, Post-Translational / drug effects
-
Thrombosis / etiology
-
Thrombosis / genetics
-
Thrombosis / metabolism
-
Ticlopidine / analogs & derivatives*
-
Ticlopidine / antagonists & inhibitors
-
Ticlopidine / pharmacology
-
Vasodilator-Stimulated Phosphoprotein
Substances
-
Cell Adhesion Molecules
-
Enzyme Inhibitors
-
Microfilament Proteins
-
Phosphoproteins
-
Platelet Aggregation Inhibitors
-
Vasodilator-Stimulated Phosphoprotein
-
Clopidogrel
-
Mixed Function Oxygenases
-
Aryl Hydrocarbon Hydroxylases
-
CYP2C19 protein, human
-
Cytochrome P-450 CYP2C19
-
Omeprazole
-
Ticlopidine
-
Aspirin